Abstract
DHCR7 and SC5D are enzymes crucial for cholesterol biosynthesis, and mutations in their genes are associated with developmental disorders, which are characterized by craniofacial deformities. We have recently reported that a loss of either Dhcr7 or Sc5d results in a failure in osteoblast differentiation. However, it remains unclear to what extent a loss of function in either DHCR7 or SC5D affects craniofacial skeletal formation. Here, using micro computed tomography (μCT), we found that the bone phenotype differs in Dhcr7−/− and Sc5d−/− mice in a location-specific fashion. For instance, in Sc5d−/− mice, although craniofacial bones were overall affected, some bone segments, such as the anterior part of the premaxilla, the anterior–posterior length of the frontal bone, and the main body of the mandible, did not present significant differences compared to WT controls. By contrast, in Dhcr7−/− mice, while craniofacial bones were not much affected, the frontal bone was larger in width and volume, and the maxilla and palatine bone were hypoplastic, compared to WT controls. Interestingly the mandible in Dhcr7−/− mice was mainly affected at the condylar region, not the body. Thus, these results help us understand which bones and how greatly they are affected by cholesterol metabolism aberrations in Dhcr7−/− and Sc5d−/− mice.
Similar content being viewed by others
Introduction
Cholesterol is a source of bile acids, steroid hormones, and oxysterols in the body and is a vital component of cellular membranes1. Cholesterol biosynthesis is regulated through multiple, highly coordinated steps, which involve over 30 reactions catalyzed by more than 15 enzymes2. Sterol-C5-desaturase (SC5D) converts cholesta-7,24-dien-3β-ol and lathosterol into 7-dehydrodesmosterol (7-DHD) and 7-dehydrocholesterol (7-DHC), whereas 7-dehydrocholesterol reductase (DHCR7) catalyzes 7-DHD and 7-DHC to desmosterol and cholesterol.
Recent studies indicate that dysregulation of cholesterol synthesis is associated with various bone disorders and diseases3. In humans, mutations in SC5D cause lathosterolosis, which is characterized by growth retardation and intellectual disability, short limbs, polydactyly/syndactyly, and craniofacial malformations including cleft palate, micrognathia, midfacial hypoplasia, and calvarial defects4. Mutations in DHCR7 cause Smith-Lemli-Opitz syndrome (SLOS), with cleft palate, postaxial polydactyly, 2–3 toe syndactyly, microcephaly, micrognathia, and intellectual disability as manifestations in humans5,6. Dysfunction of SC5D and DHCR7 leads to lathosterolosis and desmosterolosis, respectively7,8,9,10,11. Thus, these clinical manifestations and biochemical features suggest that the inborn errors associated with cholesterol biosynthesis are mainly due to the accumulation of cholesterol precursors, and not due to lower mature cholesterol levels.
As seen in humans, mice deficient for Sc5d and Dhcr7 display defects in bone formation1,3. Specifically, mice deficient for Sc5d (Sc5d−/− mice; hereafter Sc5d KO mice) exhibit cleft palate, micrognathia, agenesis of the lower incisors, calvaria hypomineralization (defects in intramembranous ossification), malformations in the long bones (defects in endochondral ossification), and syndactyly/polydactyly4,12, whereas mice deficient for Dhcr7 (Dhcr7−/− mice; hereafter Dhcr7 KO mice) exhibit accelerated calvarial bone formation and cleft palate, but only in 9% of the mutant mice13,14. Moreover, although increased levels of cholesterol precursors and lower levels of mature cholesterol in serum and tissues are commonly detected in newborn Sc5d KO and Dhcr7 KO mice4,15,16, these mouse models show different protein expression profiling in the brain17. In addition, Sc5d KO and Dhcr7 KO mice display craniofacial skeletal anomalies due to altered hedgehog and WNT/β-catenin signaling pathways at different extents and locations14,18. These results suggest that the phenotypic differences between Sc5d KO and Dhcr7 KO mice may be due to the accumulation of different cholesterol precursors.
Previous studies showed that cholesterol metabolism aberrations lead to craniofacial bone anomalies3; however, it remains unclear how an aberrant accumulation of cholesterol intermediates or loss of mature cholesterol specifically affects bone morphology. In this study, we investigated how the accumulated cholesterol precursors affect bone size in mouse models with a deficiency in cholesterol biosynthesis. Comparing the size of craniofacial bones across these mouse models allows us to identify specific areas that are affected during craniofacial development. To determine the contributions of ectopic accumulation of different cholesterol intermediates, as well as of the absence of mature cholesterol, to the pathogenesis of these diseases, we analyzed bone morphology in Sc5d KO and Dhcr7 KO mice with high-resolution μCT, and measured length and volume using 3D-reconstructed images.
Materials and methods
Animals
Sc5d+/- and Dhcr7+/− mice were a gift from Dr. Forbes D. Porter (The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA). Genotyping was performed using PCR primers as previously described4,14. All mice were bred under pathogen-free conditions, with free access to water and food and a 12-h light/dark cycle, in the UTHealth animal facility. All animal experiments were reviewed and approved by the Animal Welfare Committee (AWC) and the Institutional Animal Care and Use Committee of UTHealth (AWC-22–0087). All methods were performed in accordance with the relevant guidelines and regulations provided by ARRIVE (Animal Research: Reporting of In vivo Experiments).
μCT scanning and three-dimensional (3D) reconstruction
Pregnant mice were euthanized through carbon dioxide (CO2) inhalation, and embryos were euthanized through CO2 inhalation followed by decapitation, according to the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals. Embryos were collected at embryonic day (E) E18.5, fixed with 4% paraformaldehyde overnight, and stored in cold phosphate-buffered saline (PBS) until μCT scanning (n = 6 each genotype). The embryos were placed in a 12-mm diameter sample holder and stabilized with polypropylene straws during scanning. The μCT scans were performed at a 12-µm resolution using the SCANCO µCT-40 system (SCANCO medical USA Inc., USA; 55 kVp and 145 µA); 70% ethanol was used as the scan medium. The scanned images were analyzed using 3D-reconstructed μCT images generated with the Dragonfly software [Version 2021.1 for Windows. Object Research Systems (ORS) Inc., Montreal, Canada] with DICOM files. Craniofacial bones were isolated and labeled using the Dragonfly’s semiautomatic segmentation editor19,20. The square root of the sum of the squared distances from the centroid of the landmark configuration to each landmark was quantified as the deviation of the landmark configuration of each specimen. Basic morphometric data were analyzed with principal component analysis (PCA). The distribution of each landmark in mutants (Sc5d KO and Dhcr7 KO) and control littermates (Sc5d WT and Dhcr7 WT) along with each principal component (PC) axis was explained by PC1 and PC2. Landmarks were identified as previously described19,20 and are provided in Table 1. We used one of the landmarks as a fixed point in each bone to superimpose the images.
Statistical analysis
All results obtained were analyzed with the Prism software (GraphPad Software, California, USA). The statistical significance for multiple pairs of groups was evaluated using a two-way or one-way ANOVA with Tukey’s multiple comparison test. An adjusted p < 0.05 was statistically significant. Data are represented as dots and mean ± standard deviation (SD) in the graphs and tables. A multiple variable PCA was conducted using a standardized model, and the PCs were selected based on the percent of total explained variance.
Results
Throughout this study, we analyzed littermate wild-type (WT) mice as controls in each Dhcr7 and Sc5d strain. In addition, we confirmed that there was no significant difference between WT mice of the Dhcr7 and Sc5d strains (Tables S1-S3).
Premaxilla
We first defined the anatomical landmarks on the premaxilla in the 3D μCT images (Fig. 1A and Table 1). Next, to identify differences between WT controls and Sc5d KO and Dhcr7 KO mice, we measured the length between landmarks, as well as total bone volume, using the 3D-reconstruction images. We found that there was no significant difference in volume in the premaxilla of Dhcr7 KO and WT controls, whereas Sc5d KO mice displayed smaller premaxilla compared with either Dhcr7 KO or WT control mice (Fig. 1B and Tables 2 and 3). In Dhcr7 KO mice, the bone outline was almost indistinguishable from that in WT controls, although the volume was smaller than in WT controls. The palatal process of the premaxilla [length between point 5 and 6, adjusted P value (PAdj) = 0.035] and the body (length between point 1 and 4, PAdj < 0.001) were statistically different between Dhcr7 KO and WT control mice; however, total length (length between point 1 and 6) and width (length between point 3 and 6) were the same as those in WT mice (Fig. 1C and Tables 2 and 3). On the other hand, in Sc5d KO mice, bone volume was significantly smaller than in WT control and Dhcr7 KO mice. Anterior–posterior lengths (between 1 and 6, and 5 and 6, respectively) and height (point 3 and 4) were significantly shorter than in WT and Dhcr7 KO mice. Interestingly, the most anterior part of the premaxilla (e.g. length between point 1 and 7) were indistinguishable in all genotypes (Fig. 1C, D and Table 2, and Tables S4-S6), indicating that these areas of the bone are not affected by cholesterol metabolism aberrations. Thus, in the premaxilla, Dhcr7 KO mice displayed no major defects, whereas Sc5d KO exhibited hypoplastic premaxilla with major changes in its posterior part.
Maxilla
We defined the anatomical landmarks on the maxilla in the 3D μCT images (Fig. 2A and Table 1). We then measured the length between each landmark, as well as total bone volume, using the 3D-reconstruction images, and found that there were no substantial differences in the main body between Dhcr7 KO and WT control mice (Fig. 2B). Interestingly, although there was no obvious cleft palate in Dhcr7 KO mice, the palatal process of the maxilla (represented as the length between point 7 and 8, PAdj < 0.001; and between 8 and 9, PAdj < 0.001) was smaller than that in WT controls (Fig. 2C and Table 2, and Table S4). In Sc5d KO mice, due to cleft palate, the right-left distance between paired maxillary bones (L6‒R6 and L9‒R9) was longer compared to Dhcr7 KO and WT control mice (Fig. 2C and Table 2, and Table S4). The distal part of the maxilla (length between point 1 and 3, PAdj = 0.324; and between 3 and 6, PAdj = 0.342) was not altered in Sc5d KO mice, whereas the palatal process of the maxilla (point 7 and 8) was missing due to cleft palate (Fig. 2C, D and Table 2, and Tables S4-S6). Interestingly, the posterior part of the maxilla was curved outward (represented by the width between left and right point 5 [L5‒R5], PAdj < 0.001) and was longer in Sc5d KO mice than in WT and Dhcr7 KO mice (Fig. 2C, D and Table 2, and Tables S4-S6). In addition, the frontal process of the maxilla (height between point 1 and 10) was significantly underdeveloped in Sc5d KO mice compared to Dhcr7 KO and WT control mice (Fig. 2B and C). Overall, the volume of the maxilla was reduced in both Dhcr7 KO and Sc5d KO mice, but more significantly in Sc5d KO mice (Fig. 2C, D and Table 3, and Tables S4-S6). Thus, Dhcr7 KO mice showed mild bony defects in the maxilla, whereas Sc5d KO mice exhibited major defects in the medial part due to cleft palate.
Palatine bone
We defined the anatomical landmarks on the palatine bone in the 3D μCT images (Fig. 3A and Table 1). Next, to identify anomalies in the palatine bone, we measured the length between landmarks, as well as total bone volume, using the 3D-reconstruction images of WT controls and Sc5d KO and Dhcr7 KO mice. We found bony defects in the palatine bone in both Dhcr7 KO and Sc5d KO mice, which showed reduced anterior–posterior length, medial–lateral width, and height (Fig. 3B). In agreement with our observations for the maxilla, the size of the palatine bone (represented as the length between point 1 and 4, PAdj < 0.001; width between point 3 and 5, PAdj < 0.001; and height between point 1 and 7, PAdj < 0.001; and between point 3 and 5, PAdj < 0.001) was affected in Dhcr7 KO mice (Fig. 3C, D and Table 2, and Tables S4-S6). In Sc5d KO mice, the palatal process of the palatine bone was underdeveloped (point 5 and 6), resulting in cleft palate (Fig. 3C, D and Table 2, and Tables S4-S6). Interestingly, the anterior part of the palatine bones was rotated outward; therefore, the anterior part was wider than in WT controls (width between right and left point 2 [L2‒R2], PAdj < 0.001; and between right and left point 3 [L3‒R3], PAdj < 0.001), as seen in the posterior part of the maxilla (Figs. 2C, 3C and Table 2, and Tables S4-S6). The volume of the palatine bone was reduced in both Dhcr7 KO (PAdj = 0.004) and Sc5d KO mice (PAdj < 0.001), but more pronouncedly in Sc5d KO mice (Fig. 3C, D and Table 3, and Tables S4-S6). Importantly, there was no significant difference in the anterior–posterior length of the palatine bone (length between point 1 and 4) between Dhcr7 KO (PAdj < 0.001) and Sc5d KO (PAdj < 0.001) mice, indicating that this defect was mainly due to loss of mature cholesterol.
Frontal bone
We defined the anatomical landmarks on the frontal bone in the 3D μCT images (Fig. 4A and Table 1). Next, to identify anomalies in the frontal bone, we measured the length between landmarks, as well as total bone volume, using the 3D-reconstruction images of WT controls and Sc5d KO and Dhcr7 KO mice and found that bone mineralization was reduced in Sc5d KO mice and increased in Dhcr7 KO mice (Fig. 4A and B). Therefore, the metopic sutures (right-left distance between point 1 [L1‒R1], PAdj < 0.001; between point 2 [L2‒R2], PAdj < 0.001; and between point 6 [L6‒R6], PAdj < 0.001) were narrower in Dhcr7 KO mice, and wider in Sc5d KO mice, compared to WT mice (Fig. 4C, D and Table 2, and Tables S4-S6). In agreement with these changes, the volume of the frontal bone in Dhcr7 KO mice was increased (PAdj < 0.001), and that in Sc5d KO mice was reduced (PAdj < 0.001), compared to WT controls (Fig. 4C, D and Table 3, and Tables S4-S6). Interestingly, the anterior–posterior length of the frontal bones (length between point 1 and 2) was not changed in Sc5d KO (PAdj = 0.192) and Dhcr7 KO (PAdj = 0.994) mice compared to WT control mice, indicating that it was not affected by any of the cholesterol metabolism aberrations (Fig. 4C, D and Table 2, and Tables S4-S6). By contrast, the height between point 3 and 4 was shorter in both Dhcr7 KO (PAdj = 0.034) and Sc5d KO (PAdj < 0.001) mice, but no difference was observed between Dhcr7 KO and Sc5d KO mice, indicating that this area of the bone was affected by loss of mature cholesterol (Fig. 4C, D and Table 2, and Tables S4-S6). Taken together, our results indicate that formation of the frontal bone may be differently regulated compared to other bones studied in this study.
Mandible
We defined the anatomical landmarks on the mandible in the 3D μCT images (Fig. 5A and Table 1). Next, to identify differences in the bone phenotype, we measured the length between landmarks, as well as total bone volume, using the 3D-reconstruction images of WT controls and Sc5d KO and Dhcr7 KO mice and found that Sc5d KO mice displayed severe bone defects in size at the anterior and posterior parts of the mandible (Fig. 5B). We observed a missing extension along with the incisor due to mandibular incisor agenesis (point 1 and 2) and missing condylar (point 7, 8, 9, and 10), coronoid (point 5, 6, and 7), and angular (point 10 and 11) processes in the mandible (Fig. 5A and B). Interestingly, the main body of mandibular bone was not affected in both Sc5d KO and Dhcr7 KO mice (anterior–posterior length between point 3 and 13, PAdj = 0.942; height between point 4 and 14, PAdj > 0.999; and height between point 5 and 12, PAdj = 0.48) (Fig. 5C, D and Table 2, and Tables S4-S6). These results suggest that the extension of each process of the mandible (ramus and condylar, and coronoid processes) is highly sensitive to elevated cholesterol intermediates. The volume of the mandible was therefore decreased in both Dhcr7 KO and Sc5d KO mice compared to WT controls (Fig. 5C, D and Table 3, and Tables S4-S6). Interestingly, the angle of the left and right mandible (angle R8‒1‒L8, PAdj < 0.001) was greater in Sc5d KO mice compared to Dhcr7 KO and WT control mice (Fig. 5C, D and Table 4, and Tables S4-S6), which may be due to adaptation to the widened palatine bone in Sc5d KO mice and/or due to independent changes caused by a shorter mandible length.
Discussion
Loss of Dhcr7 or Sc5d leads to lack of mature cholesterol as well as accumulation of cholesterol intermediates, namely of 7-DHD/7-DHC or lathosterol/dehydrolathosterol, respectively. Considering the fact that phenotypes in Dhcr7 KO mice are partially rescued with statins, which normalize the levels of cholesterol precursors14, craniofacial bone development is more sensitive to the accumulation of cholesterol intermediates than to absence of mature cholesterol. More recently, we have reported that mice with a deficiency for Sc5d exhibit mandibular hypoplasia due to defects in osteoblast differentiation18. Sc5d KO mice are smaller than littermate controls and present developmental delay and bent shorter limbs4,18. Interestingly, while Sc5d KO mice display severe defects in both endochondral and intramembranous ossification, Dhcr7 KO mice show less severe bone defects14,18. The phenotypic differences between Dhcr7 KO and Sc5d KO mice may depend on the expression pattern of Dhcr7 and Sc5d. In addition, molecules that are modified with cholesterol may be differentially expressed at each bone and location during craniofacial development. For instance, hedgehog ligands (Sonic Hedgehog [SHH], Indian Hedgehog [IHH], and Desert Hedgehog [DHH]) and receptor Smoothened (SMO) are known to be modified with cholesterol, which is crucial for their distribution and activity21,22. For example, an absent cholesterol modification on SHH (ShhN) leads to a shorter distribution and lower activation of SHH signaling in limb buds, but no difference in its biological functions compared to the cholesterol-modified molecules23,24. Although oxysterols have a variety of biological activities and affect cell survival, apoptosis, gene expression, as well as Hedgehog signaling activity, it remains unknown to what extent oxysterols derived from 7-DHC, lathosterol, and cholesterol differ in cell toxicity25,26. In addition, the plasma membrane contains cholesterol-rich micro-domains (e.g. lipid rafts and caveolae) that act as a signaling center by assembling receptors and channels27,28, and transduction and activation of hedgehog signaling is regulated by oxysterols and binding of cholesterol on the membrane29,30,31. Therefore, a precisely controlled cholesterol synthesis process is important for cellular functions. Our results show that bone formation was differently affected in each mutant mouse model analyzed, indicating a location-specific requirement and the role of cholesterol metabolism in bone development.
This study shows how bone formation (e.g. size and volume) is affected in each craniofacial bone from Dhcr7 KO and Sc5d KO mice. We found that loss of mature cholesterol had a lower impact on bone formation than elevated levels of cholesterol intermediates. In the mandible, the extension of the process of the mandible was drastically affected in Sc5d KO mice compared to Dhcr7 KO and WT control mice. Because these areas are formed through endochondral ossification, chondrocytes may be more sensitive to elevated cholesterol intermediates compared to osteoblasts. Future studies may identify specific functions for each cholesterol intermediate in various cell types.
One of the limitations of this study is that there are some differences in the phenotypes observed in humans and mice. For instance, while DHCR7 mutations in humans causes SLOS with growth retardation, microcephaly, micrognathia, and cleft palate, Dhcr7 KO mice display a distinct cleft palate with less than 10% penetrance16. It should be noted that, in this study, we analyzed Dhcr7 KO mice without cleft palate. In addition, while a larger volume for the frontal bone was seen in Dhcr7 KO mice compared to WT littermates, Dhcr7 KO mice displayed smaller skulls at birth14. The accelerated bone formation and differentiation observed in Dhcr7 KO mice14 might lead to immature closure of sutures between bones as well as growth arrest in the growth plate of long bones. In humans, children with SLOS typically show a head circumference 2 standard deviations below the average of unaffected children. Although no three dimensional volumetric analysis was conducted in this study, overall craniofacial features seem to be conserved in Dhcr7 KO mice. Thus, the findings in mouse models need to be further evaluated in SLOS patients.
Data availability
All data needed to evaluate the conclusions in the paper are present in the article and/or the supplemental materials. Additional data related to this paper are available from the corresponding author upon reasonable request.
References
Porter, F. D. & Herman, G. E. Malformation syndromes caused by disorders of cholesterol synthesis. J. Lipid. Res. 52, 6–34. https://doi.org/10.1194/jlr.R009548 (2011).
Dietschy, J. M., Turley, S. D. & Spady, D. K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid. Res. 34, 1637–1659 (1993).
Suzuki, A., Minamide, M., Iwaya, C., Ogata, K. & Iwata, J. Role of metabolism in bone development and homeostasis. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21238992 (2020).
Krakowiak, P. A. et al. Lathosterolosis: An inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum. Mol. Genet. 12, 1631–1641. https://doi.org/10.1093/hmg/ddg172 (2003).
Porter, F. D. Smith-Lemli-Opitz syndrome: Pathogenesis, diagnosis and management. Eur. J. Hum. Genet. 16, 535–541. https://doi.org/10.1038/ejhg.2008.10 (2008).
Fitzky, B. U. et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc. Natl. Acad. Sci. USA 95, 8181–8186 (1998).
Waterham, H. R. Defects of cholesterol biosynthesis. FEBS Lett. 580, 5442–5449. https://doi.org/10.1016/j.febslet.2006.07.027 (2006).
Andersson, H. C., Kratz, L. & Kelley, R. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am. J. Med. Genet. 113, 315–319. https://doi.org/10.1002/ajmg.b.10873 (2002).
Yaplito-Lee, J. et al. Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis-A case report and review of literature. JIMD Rep. 56, 14–19. https://doi.org/10.1002/jmd2.12158 (2020).
Ho, A. C. et al. Lathosterolosis: A disorder of cholesterol biosynthesis resembling smith-lemli-opitz syndrome. JIMD Rep. 12, 129–134. https://doi.org/10.1007/8904_2013_255 (2014).
Kelley, R. I. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin. Chim. Acta 236, 45–58. https://doi.org/10.1016/0009-8981(95)06038-4 (1995).
Gondre-Lewis, M. C. et al. Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature. J. Cell. Sci. 119, 1876–1885. https://doi.org/10.1242/jcs.02906 (2006).
Fitzky, B. U. et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 108, 905–915. https://doi.org/10.1172/JCI12103 (2001).
Suzuki, A. et al. Disruption of Dhcr7 and Insig1/2 in cholesterol metabolism causes defects in bone formation and homeostasis through primary cilium formation. Bone. Res. 8, 1. https://doi.org/10.1038/s41413-019-0078-3 (2020).
Wechsler, A. et al. Generation of viable cholesterol-free mice. Science 302, 2087. https://doi.org/10.1126/science.1090776 (2003).
Wassif, C. A. et al. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith–Lemli–Opitz syndrome. Hum. Mol. Genet. 10, 555–564. https://doi.org/10.1093/hmg/10.6.555 (2001).
Jiang, X. S., Backlund, P. S., Wassif, C. A., Yergey, A. L. & Porter, F. D. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency. Mol. Cell Proteom. 9, 1461–1475. https://doi.org/10.1074/mcp.M900548-MCP200 (2010).
Iwaya, C., Suzuki, A. & Iwata, J. Loss of Sc5d results in micrognathia due to a failure in osteoblast differentiation. J. Adv. Res. https://doi.org/10.1016/j.jare.2023.12.008 (2023).
Shim, J., Iwaya, C., Ambrose, C. G., Suzuki, A. & Iwata, J. Micro-computed tomography assessment of bone structure in aging mice. Sci. Rep. 12, 8117. https://doi.org/10.1038/s41598-022-11965-4 (2022).
Ho, T. V. et al. Integration of comprehensive 3D microCT and signaling analysis reveals differential regulatory mechanisms of craniofacial bone development. Dev. Biol. 400, 180–190. https://doi.org/10.1016/j.ydbio.2015.02.010 (2015).
Xiao, X. et al. Cholesterol modification of smoothened is required for hedgehog signaling. Mol. Cell. 66(154–162), e110. https://doi.org/10.1016/j.molcel.2017.02.015 (2017).
Porter, J. A., Young, K. E. & Beachy, P. A. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274, 255–259. https://doi.org/10.1126/science.274.5285.255 (1996).
Lewis, P. M. et al. Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105, 599–612. https://doi.org/10.1016/s0092-8674(01)00369-5 (2001).
Li, Y., Zhang, H., Litingtung, Y. & Chiang, C. Cholesterol modification restricts the spread of Shh gradient in the limb bud. Proc. Natl. Acad. Sci. USA 103, 6548–6553. https://doi.org/10.1073/pnas.0600124103 (2006).
Olkkonen, V. M., Beaslas, O. & Nissila, E. Oxysterols and their cellular effectors. Biomolecules 2, 76–103. https://doi.org/10.3390/biom2010076 (2012).
Nedelcu, D., Liu, J., Xu, Y., Jao, C. & Salic, A. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling. Nat. Chem. Biol. 9, 557–564. https://doi.org/10.1038/nchembio.1290 (2013).
Zakany, F., Kovacs, T., Panyi, G. & Varga, Z. Direct and indirect cholesterol effects on membrane proteins with special focus on potassium channels. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1865, 158706. https://doi.org/10.1016/j.bbalip.2020.158706 (2020).
Ouweneel, A. B., Thomas, M. J. & Sorci-Thomas, M. G. The ins and outs of lipid rafts: Functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: Thematic review series: Biology of lipid rafts. J. Lipid. Res. 61, 676–686. https://doi.org/10.1194/jlr.TR119000383 (2020).
Kinnebrew, M. et al. Cholesterol accessibility at the ciliary membrane controls hedgehog signaling. Elife https://doi.org/10.7554/eLife.50051 (2019).
Findakly, S. et al. Sterol and oxysterol synthases near the ciliary base activate the Hedgehog pathway. J. Cell. Biol. https://doi.org/10.1083/jcb.202002026 (2021).
Raleigh, D. R. et al. Cilia-associated oxysterols activate smoothened. Mol. Cell. 72(316–327), e315. https://doi.org/10.1016/j.molcel.2018.08.034 (2018).
Acknowledgements
We thank members of the MicroCT Lab of Baylor College of Medicine for technical assistance. We thank Dr. Forbes D. Porter at The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, for providing the Sc5d and Dhcr7 KO mice. This study was supported by grants from the National Institute of Dental and Craniofacial Research, the NIH (R01DE026767 and R01DE029818 to JI), and UTHealth School of Dentistry faculty funding to JI.
Author information
Authors and Affiliations
Contributions
C.I. Investigation, Methodology, Visualization, Writing- original draft, review & editing; A.S. Methodology, Visualization, Writing-review & editing; J.S. Investigation; A.K. Investigation; J.I. Funding acquisition, Supervision, Conceptualization, Investigation, Methodology, Writing-original draft, Writing-review & editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Iwaya, C., Suzuki, A., Shim, J. et al. Craniofacial bone anomalies related to cholesterol synthesis defects. Sci Rep 14, 5371 (2024). https://doi.org/10.1038/s41598-024-55998-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-55998-3
- Springer Nature Limited